Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ·Healthcare·Biotechnology
$477.86
+1.53%
Mkt Cap $121.09B
Analyst Ratings
Buy
21
Hold
4
Sell
1
Price Target (93 analysts)
$553.93
Range $436.00 – $616.00
Implied Upside
+15.9%
Consensus $553.93 vs current $477.86